Drug Database
Back to search

France· FR:66064587

TRILEPTAL 60 mg/ml, suspension buvable

A oxcarbazepine product containing oxcarbazépine, registered in France by NOVARTIS PHARMA, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N03AF02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTRILEPTAL 60 mg/ml, suspension buvableATCN03AF02REGISTER NO.FR:66064587PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxcarbazépineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxcarbazepine is registered in 15 of 19 countries.

Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search oxcarbazepine products by name

Oxcarbazepine · ATC N03AF02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxcarbazepine costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.

  • France: $1.08 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Oxcarbazepine · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.54
  • FR France$1.08
  • IT Italy$0.73
  • US United States$0.56 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OXCARBAZÉPINE
Manufacturer
NOVARTIS PHARMA
Country
France (FR)
ATC code
N03AF02
ATC class
Oxcarbazepine
Defined daily dose
1 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400935790125
    1 flacon(s) en verre jaune(brun) de 250 ml avec adaptateur avec seringue(s) pour administration orale polypropylène
    EUR 27.96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for oxcarbazepine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxcarbazepine against other medicinesHow interaction checks work

Oxcarbazepine · interactions on record

398 records

  • 8 severe
  • 263 moderate
  • 7 minor
  • 72 info

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxcarbazepine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxcarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Trileptal
  • Belgium · Oxcarbazepine Viatris, Trileptal
  • Bulgaria · Трилептал
  • Cyprus · Oxcarbazepine Jubilant, Trileptal
  • Germany · Apydan Extent, Oxcarbazepin 1 A Pharma
  • Denmark · Apydan, Oxcarbazepin Jubilant
  • Estonia · Apydan, Trileptal
  • Spain · Oxcarbazepina Cinfa, Oxcarbazepina Normon
  • Finland · Apydan, Oxcarbazepin Orion
  • United Kingdom (Northern Ireland) · Oxcarbazepine, Oxcarbazepine Amarox
  • Greece · Trileptal
  • Croatia · Trileptal
  • Hungary · Trileptal
  • Ireland · Trileptal
  • Iceland · Oxcarbazepine Jubilant, Trileptal
  • Italy · Oxcarbazepina Tecnigen, Tolep
  • Lithuania · Trileptal
  • Latvia · Trileptal
  • Netherlands · Oxcarbazepine Adoh, Oxcarbazepine Jubilant
  • Norway · Trileptal
  • Poland · Karbagen, Oxepilax
  • Portugal · Epilfarmo, Oxcarbazepina Biofarmoz
  • Romania · Trileptal
  • Sweden · Trileptal
  • Slovenia · Karbox
  • Slovakia · Trileptal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2bb4574b-c8f7-4e81-9739-6758a5a9c732
GET /v1/drugs/2bb4574b-c8f7-4e81-9739-6758a5a9c732?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66064587",
  "date_amm": "2001-10-26",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "OXCARBAZÉPINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about oxcarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console